APO RESEARCH · REPORT
Equine Healthcare
Equine health refers to veterinary services intended to treat horses to enhance their quality of life. The equine healthcare market is an emerging field of pharmaceuticals.
Product & engineering
Understand the product.
Equine health refers to veterinary services intended to treat horses to enhance their quality of life. The equine healthcare market is an emerging field of pharmaceuticals.
Selected research
Industry Research
Equine Healthcare Industry Research Report 2026
Market perspective
Equine health refers to veterinary services intended to treat horses to enhance their quality of life. The equine healthcare market is an emerging field of pharmaceuticals.
The top 13 manufacturers held about 75.03% of the market share in 2019.
Report Scope
Read the full market overview
This report quantifies the global Equine Healthcare market in terms of revenue (US$ million) and, where applicable, service volume (), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Equine Healthcare.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Equine Healthcare Market by Company
Boehringer Ingelheim
Merck Animal Health
Zoetis
Bayer Animal Health
Elanco Animal Health
Ceva Animal Health
Dechra Veterinary Products
Purina Mills
Norbrook Equine
Virbac
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Equine Healthcare Segment by Type
Equine Diagnostic Products
Equine Therapeutic Products
Equine Supplement Products
Equine Healthcare Segment by Application
Veterinary Hospitals and Clinics
Retail Pharmacies and Drug Stores
Others
Equine Healthcare Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Equine Healthcare market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Equine Healthcare and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Equine Healthcare.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Equine Healthcare companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Equine Diagnostic Products
- Equine Therapeutic Products
- Equine Supplement Products
Applications
- Veterinary Hospitals and Clinics
- Retail Pharmacies and Drug Stores
- Others
Companies covered
- Boehringer Ingelheim
- Merck Animal Health
- Zoetis
- Bayer Animal Health
- Elanco Animal Health
- Ceva Animal Health
- Dechra Veterinary Products
- Purina Mills
- Norbrook Equine
- Virbac
- Kyoritsu Seiyaku
- Vetoquinol
- Protexin Healthcare
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Equine Healthcare by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Equine Diagnostic Products
- 2.2.3 Equine Therapeutic Products
- 2.2.4 Equine Supplement Products
- 2.3 Equine Healthcare by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Veterinary Hospitals and Clinics
- 2.3.3 Retail Pharmacies and Drug Stores
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Equine Healthcare Breakdown Data by Type
- 3.1 Global Equine Healthcare Historic Market Size by Type (2021-2026)
- 3.2 Global Equine Healthcare Forecasted Market Size by Type (2027-2032)
4 Equine Healthcare Breakdown Data by Application
- 4.1 Global Equine Healthcare Historic Market Size by Application (2021-2026)
- 4.2 Global Equine Healthcare Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Equine Healthcare Market Perspective (2021-2032)
- 5.2 Global Equine Healthcare Growth Trends by Region
- 5.2.1 Global Equine Healthcare Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Equine Healthcare Historic Market Size by Region (2021-2026)
- 5.2.3 Equine Healthcare Forecasted Market Size by Region (2027-2032)
- 5.3 Equine Healthcare Market Dynamics
- 5.3.1 Equine Healthcare Industry Trends
- 5.3.2 Equine Healthcare Market Drivers
- 5.3.3 Equine Healthcare Market Challenges
- 5.3.4 Equine Healthcare Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Equine Healthcare Players by Revenue
- 6.1.1 Global Top Equine Healthcare Players by Revenue (2021-2026)
- 6.1.2 Global Equine Healthcare Revenue Market Share by Players (2021-2026)
- 6.2 Global Equine Healthcare Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Equine Healthcare Head Office and Area Served
- 6.4 Global Equine Healthcare Players, Product Type & Application
- 6.5 Global Equine Healthcare Manufacturers Established Date
- 6.6 Global Equine Healthcare Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Equine Healthcare Market Size (2021-2032)
- 7.2 North America Equine Healthcare Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Equine Healthcare Market Size by Country (2021-2026)
- 7.4 North America Equine Healthcare Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Equine Healthcare Market Size (2021-2032)
- 8.2 Europe Equine Healthcare Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Equine Healthcare Market Size by Country (2021-2026)
- 8.4 Europe Equine Healthcare Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Equine Healthcare Market Size (2021-2032)
- 9.2 Asia-Pacific Equine Healthcare Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Equine Healthcare Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Equine Healthcare Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Equine Healthcare Market Size (2021-2032)
- 10.2 South America Equine Healthcare Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Equine Healthcare Market Size by Country (2021-2026)
- 10.4 South America Equine Healthcare Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Equine Healthcare Market Size (2021-2032)
- 11.2 Middle East & Africa Equine Healthcare Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Equine Healthcare Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Equine Healthcare Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Boehringer Ingelheim
- 12.1.1 Boehringer Ingelheim Company Information
- 12.1.2 Boehringer Ingelheim Business Overview
- 12.1.3 Boehringer Ingelheim Revenue in Equine Healthcare Business (2021-2026)
- 12.1.4 Boehringer Ingelheim Equine Healthcare Product Portfolio
- 12.1.5 Boehringer Ingelheim Recent Developments
- 12.2 Merck Animal Health
- 12.2.1 Merck Animal Health Company Information
- 12.2.2 Merck Animal Health Business Overview
- 12.2.3 Merck Animal Health Revenue in Equine Healthcare Business (2021-2026)
- 12.2.4 Merck Animal Health Equine Healthcare Product Portfolio
- 12.2.5 Merck Animal Health Recent Developments
- 12.3 Zoetis
- 12.3.1 Zoetis Company Information
- 12.3.2 Zoetis Business Overview
- 12.3.3 Zoetis Revenue in Equine Healthcare Business (2021-2026)
- 12.3.4 Zoetis Equine Healthcare Product Portfolio
- 12.3.5 Zoetis Recent Developments
- 12.4 Bayer Animal Health
- 12.4.1 Bayer Animal Health Company Information
- 12.4.2 Bayer Animal Health Business Overview
- 12.4.3 Bayer Animal Health Revenue in Equine Healthcare Business (2021-2026)
- 12.4.4 Bayer Animal Health Equine Healthcare Product Portfolio
- 12.4.5 Bayer Animal Health Recent Developments
- 12.5 Elanco Animal Health
- 12.5.1 Elanco Animal Health Company Information
- 12.5.2 Elanco Animal Health Business Overview
- 12.5.3 Elanco Animal Health Revenue in Equine Healthcare Business (2021-2026)
- 12.5.4 Elanco Animal Health Equine Healthcare Product Portfolio
- 12.5.5 Elanco Animal Health Recent Developments
- 12.6 Ceva Animal Health
- 12.6.1 Ceva Animal Health Company Information
- 12.6.2 Ceva Animal Health Business Overview
- 12.6.3 Ceva Animal Health Revenue in Equine Healthcare Business (2021-2026)
- 12.6.4 Ceva Animal Health Equine Healthcare Product Portfolio
- 12.6.5 Ceva Animal Health Recent Developments
- 12.7 Dechra Veterinary Products
- 12.7.1 Dechra Veterinary Products Company Information
- 12.7.2 Dechra Veterinary Products Business Overview
- 12.7.3 Dechra Veterinary Products Revenue in Equine Healthcare Business (2021-2026)
- 12.7.4 Dechra Veterinary Products Equine Healthcare Product Portfolio
- 12.7.5 Dechra Veterinary Products Recent Developments
- 12.8 Purina Mills
- 12.8.1 Purina Mills Company Information
- 12.8.2 Purina Mills Business Overview
- 12.8.3 Purina Mills Revenue in Equine Healthcare Business (2021-2026)
- 12.8.4 Purina Mills Equine Healthcare Product Portfolio
- 12.8.5 Purina Mills Recent Developments
- 12.9 Norbrook Equine
- 12.9.1 Norbrook Equine Company Information
- 12.9.2 Norbrook Equine Business Overview
- 12.9.3 Norbrook Equine Revenue in Equine Healthcare Business (2021-2026)
- 12.9.4 Norbrook Equine Equine Healthcare Product Portfolio
- 12.9.5 Norbrook Equine Recent Developments
- 12.10 Virbac
- 12.10.1 Virbac Company Information
- 12.10.2 Virbac Business Overview
- 12.10.3 Virbac Revenue in Equine Healthcare Business (2021-2026)
- 12.10.4 Virbac Equine Healthcare Product Portfolio
- 12.10.5 Virbac Recent Developments
- 12.11 Kyoritsu Seiyaku
- 12.11.1 Kyoritsu Seiyaku Company Information
- 12.11.2 Kyoritsu Seiyaku Business Overview
- 12.11.3 Kyoritsu Seiyaku Revenue in Equine Healthcare Business (2021-2026)
- 12.11.4 Kyoritsu Seiyaku Equine Healthcare Product Portfolio
- 12.11.5 Kyoritsu Seiyaku Recent Developments
- 12.12 Vetoquinol
- 12.12.1 Vetoquinol Company Information
- 12.12.2 Vetoquinol Business Overview
- 12.12.3 Vetoquinol Revenue in Equine Healthcare Business (2021-2026)
- 12.12.4 Vetoquinol Equine Healthcare Product Portfolio
- 12.12.5 Vetoquinol Recent Developments
- 12.13 Protexin Healthcare
- 12.13.1 Protexin Healthcare Company Information
- 12.13.2 Protexin Healthcare Business Overview
- 12.13.3 Protexin Healthcare Revenue in Equine Healthcare Business (2021-2026)
- 12.13.4 Protexin Healthcare Equine Healthcare Product Portfolio
- 12.13.5 Protexin Healthcare Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst